Sontra Medical Corporation Received U.S. Patent for Non-Invasive Body Fluid Sampling and Analysis

Filed in archive Diagnostics on July 27, 2006

Sontra Medical Corporation has recently been granted U.S. Patent No. 7,066,884 entitled, "System, Method, and Device for Non-Invasive Body Fluid Sampling and Analysis" that describes the technology for transdermal continuous glucose monitoring.

"This patent further strengthens the intellectual property portfolio surrounding Sontra's non-invasive diagnostics, and is central in transdermal and continuous glucose monitoring technology," stated Scott Kellogg, Sontra's Vice President of Research and Development.

Sontra Medical Corporation's continuous non-invasive glucose monitoring
technology measures glucose diffusing through ultrasonically permeated skin for twenty- four hours. This technology has significant implications in the critical care setting, as well as in the home glucose testing.

Read more at Sontra Medical Corporation.